中国大陆老年人季节性流感疫苗接种率和疫苗有效性:系统回顾和荟萃分析

IF 7.1 2区 医学 Q1 GERIATRICS & GERONTOLOGY
Rui Ma, Yuling Du, Wenduo Jing, Hao Ma, Kerui Wang, Aonan Liu, Siran Chen, Mengqi Zhou, Yinuo Zhou, Shaohui Su, Li Zhang, Yanfang Yang
{"title":"中国大陆老年人季节性流感疫苗接种率和疫苗有效性:系统回顾和荟萃分析","authors":"Rui Ma, Yuling Du, Wenduo Jing, Hao Ma, Kerui Wang, Aonan Liu, Siran Chen, Mengqi Zhou, Yinuo Zhou, Shaohui Su, Li Zhang, Yanfang Yang","doi":"10.1093/ageing/afaf252","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Both vaccine coverage and its effectiveness determine the influence of seasonal influenza vaccination on influenza control within a population. We conducted a systematic review and meta-analysis to estimate the influenza vaccination rate (IVR) and vaccine effectiveness (VE) among older adults in mainland China.</p><p><strong>Methods: </strong>We searched five databases for the last 12 years, selecting studies that included people aged 60 years or older in mainland China. Random or fixed effects models were used to generate summary IVR and VE. The heterogeneity was assessed by subgroup analyses and meta-regression. Potential biases of the included studies were examined using the Agency for Healthcare Research and Quality Inventory and the Newcastle-Ottawa Scale.</p><p><strong>Results: </strong>For IVR, we included 65 studies, involving 149 458 672 participants. The overall pooled IVR was found to be 17% (95% CI: 14%-21%), with lower IVRs observed in areas lacking free vaccination policies (7%, 95% CI: 5%-9%) and among individuals with chronic diseases (13%, 95% CI: 8%-19%). To assess VE against laboratory-confirmed influenza, we included 14 studies, involving 13 950 participants. The overall pooled VE was 33% (95% CI: 10%-51%), with a higher VE estimate observed for influenza A(H1N1) pdm09 (51%, 95% CI: 13%-73%) and when the vaccine matched the circulating virus strain (37%, 95% CI: 9%-56%).</p><p><strong>Conclusions: </strong>IVRs among older adults in the included areas are low, especially among those lacking access to free policies and those with chronic diseases. Furthermore, the current vaccine provides low protection. It is crucial to increase influenza vaccination uptake and develop more effective vaccines for older adults.</p>","PeriodicalId":7682,"journal":{"name":"Age and ageing","volume":"54 9","pages":""},"PeriodicalIF":7.1000,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Seasonal influenza vaccination rate and vaccine effectiveness among older adults in mainland China: a systematic review and meta-analysis.\",\"authors\":\"Rui Ma, Yuling Du, Wenduo Jing, Hao Ma, Kerui Wang, Aonan Liu, Siran Chen, Mengqi Zhou, Yinuo Zhou, Shaohui Su, Li Zhang, Yanfang Yang\",\"doi\":\"10.1093/ageing/afaf252\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Both vaccine coverage and its effectiveness determine the influence of seasonal influenza vaccination on influenza control within a population. We conducted a systematic review and meta-analysis to estimate the influenza vaccination rate (IVR) and vaccine effectiveness (VE) among older adults in mainland China.</p><p><strong>Methods: </strong>We searched five databases for the last 12 years, selecting studies that included people aged 60 years or older in mainland China. Random or fixed effects models were used to generate summary IVR and VE. The heterogeneity was assessed by subgroup analyses and meta-regression. Potential biases of the included studies were examined using the Agency for Healthcare Research and Quality Inventory and the Newcastle-Ottawa Scale.</p><p><strong>Results: </strong>For IVR, we included 65 studies, involving 149 458 672 participants. The overall pooled IVR was found to be 17% (95% CI: 14%-21%), with lower IVRs observed in areas lacking free vaccination policies (7%, 95% CI: 5%-9%) and among individuals with chronic diseases (13%, 95% CI: 8%-19%). To assess VE against laboratory-confirmed influenza, we included 14 studies, involving 13 950 participants. The overall pooled VE was 33% (95% CI: 10%-51%), with a higher VE estimate observed for influenza A(H1N1) pdm09 (51%, 95% CI: 13%-73%) and when the vaccine matched the circulating virus strain (37%, 95% CI: 9%-56%).</p><p><strong>Conclusions: </strong>IVRs among older adults in the included areas are low, especially among those lacking access to free policies and those with chronic diseases. Furthermore, the current vaccine provides low protection. It is crucial to increase influenza vaccination uptake and develop more effective vaccines for older adults.</p>\",\"PeriodicalId\":7682,\"journal\":{\"name\":\"Age and ageing\",\"volume\":\"54 9\",\"pages\":\"\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2025-08-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Age and ageing\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ageing/afaf252\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Age and ageing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ageing/afaf252","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

疫苗覆盖率及其有效性决定了季节性流感疫苗接种对人群流感控制的影响。我们进行了系统回顾和荟萃分析,以估计中国大陆老年人的流感疫苗接种率(IVR)和疫苗有效性(VE)。方法:我们检索了过去12年的5个数据库,选择了包括中国大陆60岁及以上人群的研究。采用随机或固定效应模型生成总结IVR和VE。通过亚组分析和meta回归评估异质性。使用医疗保健研究机构和质量量表和纽卡斯尔-渥太华量表检查纳入研究的潜在偏差。结果:对于IVR,我们纳入了65项研究,涉及149 458 672名参与者。总体合并IVR为17% (95% CI: 14%-21%),在缺乏免费疫苗接种政策的地区(7%,95% CI: 5%-9%)和慢性病患者(13%,95% CI: 8%-19%)中观察到较低的IVR。为了评估VE对实验室确诊流感的作用,我们纳入了14项研究,涉及13950名受试者。总体汇总VE为33% (95% CI: 10%-51%),甲型H1N1流感pdm09的VE估计较高(51%,95% CI: 13%-73%),当疫苗与流行病毒株相匹配时(37%,95% CI: 9%-56%)。结论:纳入地区老年人的ivr较低,特别是缺乏免费政策的老年人和慢性病患者。此外,目前的疫苗提供的保护很低。增加流感疫苗接种并为老年人开发更有效的疫苗至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Seasonal influenza vaccination rate and vaccine effectiveness among older adults in mainland China: a systematic review and meta-analysis.

Introduction: Both vaccine coverage and its effectiveness determine the influence of seasonal influenza vaccination on influenza control within a population. We conducted a systematic review and meta-analysis to estimate the influenza vaccination rate (IVR) and vaccine effectiveness (VE) among older adults in mainland China.

Methods: We searched five databases for the last 12 years, selecting studies that included people aged 60 years or older in mainland China. Random or fixed effects models were used to generate summary IVR and VE. The heterogeneity was assessed by subgroup analyses and meta-regression. Potential biases of the included studies were examined using the Agency for Healthcare Research and Quality Inventory and the Newcastle-Ottawa Scale.

Results: For IVR, we included 65 studies, involving 149 458 672 participants. The overall pooled IVR was found to be 17% (95% CI: 14%-21%), with lower IVRs observed in areas lacking free vaccination policies (7%, 95% CI: 5%-9%) and among individuals with chronic diseases (13%, 95% CI: 8%-19%). To assess VE against laboratory-confirmed influenza, we included 14 studies, involving 13 950 participants. The overall pooled VE was 33% (95% CI: 10%-51%), with a higher VE estimate observed for influenza A(H1N1) pdm09 (51%, 95% CI: 13%-73%) and when the vaccine matched the circulating virus strain (37%, 95% CI: 9%-56%).

Conclusions: IVRs among older adults in the included areas are low, especially among those lacking access to free policies and those with chronic diseases. Furthermore, the current vaccine provides low protection. It is crucial to increase influenza vaccination uptake and develop more effective vaccines for older adults.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Age and ageing
Age and ageing 医学-老年医学
CiteScore
9.20
自引率
6.00%
发文量
796
审稿时长
4-8 weeks
期刊介绍: Age and Ageing is an international journal publishing refereed original articles and commissioned reviews on geriatric medicine and gerontology. Its range includes research on ageing and clinical, epidemiological, and psychological aspects of later life.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信